SYNTA PHARMACEUTICALS CORP - COM (SNTA)

CUSIP: 87162T206

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM
Total 13F shares
41,869,187
Share change
-4,461,879
Total reported value
$10,046,000
Put/Call ratio
0%
Price per share
$0.24
Number of holders
57
Value change
-$1,310,611
Number of buys
12
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 87162T206?
CUSIP 87162T206 identifies SNTA - SYNTA PHARMACEUTICALS CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SYNTA PHARMACEUTICALS CORP - COM (SNTA) as of Q1 2016

As of 31 Mar 2016, SYNTA PHARMACEUTICALS CORP - COM (SNTA) was held by 57 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 41,869,187 shares. The largest 10 holders included CAXTON CORP, VANGUARD GROUP INC, BlackRock Fund Advisors, RENAISSANCE TECHNOLOGIES LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, BlackRock Institutional Trust Company, N.A., NORTHERN TRUST CORP, STATE STREET CORP, CITADEL ADVISORS LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 57 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.